140 related articles for article (PubMed ID: 17189417)
21. Anti-tumor efficacy of Cloretazine (VNP40101M) alone and in combination with fludarabine in murine tumor and human xenograft tumor models.
Zheng LM; Li Z; Liu L; Song BL; King I
Cancer Chemother Pharmacol; 2007 Jun; 60(1):45-51. PubMed ID: 17256135
[TBL] [Abstract][Full Text] [Related]
22. Novel repression of the glucocorticoid receptor by anthrax lethal toxin.
Webster JI; Moayeri M; Sternberg EM
Ann N Y Acad Sci; 2004 Jun; 1024():9-23. PubMed ID: 15265771
[TBL] [Abstract][Full Text] [Related]
23. Effects of anthrax lethal toxin on human primary keratinocytes.
Koçer SS; Matic M; Ingrassia M; Walker SG; Roemer E; Licul G; Simon SR
J Appl Microbiol; 2008 Dec; 105(6):1756-67. PubMed ID: 19120626
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma.
De Stefano I; Raspaglio G; Zannoni GF; Travaglia D; Prisco MG; Mosca M; Ferlini C; Scambia G; Gallo D
Biochem Pharmacol; 2009 Dec; 78(11):1374-81. PubMed ID: 19643088
[TBL] [Abstract][Full Text] [Related]
25. BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxin.
Abi-Habib RJ; Urieto JO; Liu S; Leppla SH; Duesbery NS; Frankel AE
Mol Cancer Ther; 2005 Sep; 4(9):1303-10. PubMed ID: 16170021
[TBL] [Abstract][Full Text] [Related]
26. Cisplatin encapsulated in phosphatidylethanolamine liposomes enhances the in vitro cytotoxicity and in vivo intratumor drug accumulation against melanomas.
Hwang TL; Lee WR; Hua SC; Fang JY
J Dermatol Sci; 2007 Apr; 46(1):11-20. PubMed ID: 17267180
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of pyridoxal treatment in controlling the growth of melanomas in cell culture and an animal pilot study.
Maksymowych AB; Robertson NM; Litwack G
Anticancer Res; 1993; 13(6A):1925-37. PubMed ID: 8297098
[TBL] [Abstract][Full Text] [Related]
28. A novel transport and delivery mechanism underpins the effectiveness of prolyl-m-sarcolysyl-p-fluorophenylalanine (PSF) in a human melanoma xenograft nude-mouse model.
Dierickx KM; Morandini R; Nguyen TH; Salès F; Kauffmann JM; Ghanem GE
Pigment Cell Melanoma Res; 2008 Aug; 21(4):439-50. PubMed ID: 18627526
[TBL] [Abstract][Full Text] [Related]
29. Determination of minimum effective dose and optimal dosing schedule for liposomal curcumin in a xenograft human pancreatic cancer model.
Mach CM; Mathew L; Mosley SA; Kurzrock R; Smith JA
Anticancer Res; 2009 Jun; 29(6):1895-9. PubMed ID: 19528445
[TBL] [Abstract][Full Text] [Related]
30. Taurolidine induces apoptosis of murine melanoma cells in vitro and in vivo by modulation of the Bcl-2 family proteins.
Sun BS; Wang JH; Liu LL; Gong SL; Redmond HP
J Surg Oncol; 2007 Sep; 96(3):241-8. PubMed ID: 17469118
[TBL] [Abstract][Full Text] [Related]
31. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin.
Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137
[TBL] [Abstract][Full Text] [Related]
32. Matrix metalloproteinase-activated anthrax lethal toxin demonstrates high potency in targeting tumor vasculature.
Liu S; Wang H; Currie BM; Molinolo A; Leung HJ; Moayeri M; Basile JR; Alfano RW; Gutkind JS; Frankel AE; Bugge TH; Leppla SH
J Biol Chem; 2008 Jan; 283(1):529-540. PubMed ID: 17974567
[TBL] [Abstract][Full Text] [Related]
33. Suppression of ras-mediated transformation and inhibition of tumor growth and angiogenesis by anthrax lethal factor, a proteolytic inhibitor of multiple MEK pathways.
Duesbery NS; Resau J; Webb CP; Koochekpour S; Koo HM; Leppla SH; Vande Woude GF
Proc Natl Acad Sci U S A; 2001 Mar; 98(7):4089-94. PubMed ID: 11259649
[TBL] [Abstract][Full Text] [Related]
34. Broad antitumor activity in breast cancer xenografts by motesanib, a highly selective, oral inhibitor of vascular endothelial growth factor, platelet-derived growth factor, and Kit receptors.
Coxon A; Bush T; Saffran D; Kaufman S; Belmontes B; Rex K; Hughes P; Caenepeel S; Rottman JB; Tasker A; Patel V; Kendall R; Radinsky R; Polverino A
Clin Cancer Res; 2009 Jan; 15(1):110-8. PubMed ID: 19118038
[TBL] [Abstract][Full Text] [Related]
35. Oncolytic virotherapy for malignant melanoma with herpes simplex virus type 1 mutant HF10.
Watanabe D; Goshima F; Mori I; Tamada Y; Matsumoto Y; Nishiyama Y
J Dermatol Sci; 2008 Jun; 50(3):185-96. PubMed ID: 18226503
[TBL] [Abstract][Full Text] [Related]
36. Cytosine deaminase-producing human mesenchymal stem cells mediate an antitumor effect in a mouse xenograft model.
You MH; Kim WJ; Shim W; Lee SR; Lee G; Choi S; Kim DY; Kim YM; Kim H; Han SU
J Gastroenterol Hepatol; 2009 Aug; 24(8):1393-400. PubMed ID: 19486256
[TBL] [Abstract][Full Text] [Related]
37. Modulation of the response to chemotherapy in a human melanoma clone by the site of growth in the nude mouse.
Verschraegen CF; Mendoza JT; Kozielski AJ; Giovanella BC
Anticancer Res; 1995; 15(1):9-11. PubMed ID: 7733648
[TBL] [Abstract][Full Text] [Related]
38. Tumor-targeting amino acid auxotrophic Salmonella typhimurium.
Hoffman RM
Amino Acids; 2009 Sep; 37(3):509-21. PubMed ID: 19291366
[TBL] [Abstract][Full Text] [Related]
39. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3.
Hu-Lowe DD; Zou HY; Grazzini ML; Hallin ME; Wickman GR; Amundson K; Chen JH; Rewolinski DA; Yamazaki S; Wu EY; McTigue MA; Murray BW; Kania RS; O'Connor P; Shalinsky DR; Bender SL
Clin Cancer Res; 2008 Nov; 14(22):7272-83. PubMed ID: 19010843
[TBL] [Abstract][Full Text] [Related]
40. Nanoemulsion preparations of the anticancer drug dacarbazine significantly increase its efficacy in a xenograft mouse melanoma model.
Tagne JB; Kakumanu S; Nicolosi RJ
Mol Pharm; 2008; 5(6):1055-63. PubMed ID: 19434855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
